BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29686054)

  • 21. Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS.
    Stark R; Choi H; Koch S; Lamb F; Sherwood E
    Innate Immun; 2015 Aug; 21(6):565-74. PubMed ID: 25540284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monophosphoryl lipid A alleviated radiation-induced testicular injury through TLR4-dependent exosomes.
    Liu Z; Cao K; Liao Z; Chen Y; Lei X; Wei Q; Liu C; Sun X; Yang Y; Cai J; Gao F
    J Cell Mol Med; 2020 Apr; 24(7):3917-3930. PubMed ID: 32135028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MyD88-dependent SHIP1 regulates proinflammatory signaling pathways in dendritic cells after monophosphoryl lipid A stimulation of TLR4.
    Cekic C; Casella CR; Sag D; Antignano F; Kolb J; Suttles J; Hughes MR; Krystal G; Mitchell TC
    J Immunol; 2011 Apr; 186(7):3858-65. PubMed ID: 21339365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like Receptor Signaling Rewires Macrophage Metabolism and Promotes Histone Acetylation via ATP-Citrate Lyase.
    Lauterbach MA; Hanke JE; Serefidou M; Mangan MSJ; Kolbe CC; Hess T; Rothe M; Kaiser R; Hoss F; Gehlen J; Engels G; Kreutzenbeck M; Schmidt SV; Christ A; Imhof A; Hiller K; Latz E
    Immunity; 2019 Dec; 51(6):997-1011.e7. PubMed ID: 31851905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearance.
    Talbot S; Tötemeyer S; Yamamoto M; Akira S; Hughes K; Gray D; Barr T; Mastroeni P; Maskell DJ; Bryant CE
    Immunology; 2009 Dec; 128(4):472-83. PubMed ID: 19930040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia.
    Murugina NE; Budikhina AS; Dagil YA; Maximchik PV; Balyasova LS; Murugin VV; Melnikov MV; Sharova VS; Nikolaeva AM; Chkadua GZ; Pinegin BV; Pashenkov MV
    J Biol Chem; 2020 Mar; 295(10):3099-3114. PubMed ID: 32005665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime-protein boost HIV-1 vaccine.
    Pouliot K; Buglione-Corbett R; Marty-Roix R; Montminy-Paquette S; West K; Wang S; Lu S; Lien E
    Vaccine; 2014 Sep; 32(39):5049-56. PubMed ID: 25045815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of tolerogenic vs immunogenic dendritic cells (DCs) in the presence of GM-CSF is regulated by the strength of signaling from monophosphoryl lipid A (MPLA) in association with glutathione and fetal hemoglobin gamma-chain.
    Khatri I; Alexander C; Brandenburg K; Fournier K; Mach JP; Rietschel ET; Ulmer AJ; Terzioglu E; Waelli T; Gorczynski RM
    Immunol Lett; 2009 May; 124(1):44-9. PubMed ID: 19379773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.
    Ruckdeschel K; Pfaffinger G; Haase R; Sing A; Weighardt H; Häcker G; Holzmann B; Heesemann J
    J Immunol; 2004 Sep; 173(5):3320-8. PubMed ID: 15322195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-free hemoglobin triggers macrophage cytokine production via TLR4 and MyD88.
    Schaaf KR; Landstreet SR; Pugazenthi S; Qian EY; Putz ND; Siderova T; Owen AM; Bohannon JK; Ware LB; Bastarache JA; Shaver CM
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L29-L38. PubMed ID: 37991487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane.
    Tanimura N; Saitoh S; Ohto U; Akashi-Takamura S; Fujimoto Y; Fukase K; Shimizu T; Miyake K
    Int Immunol; 2014 Jun; 26(6):307-14. PubMed ID: 24380872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interplay Between Sialic Acids, Siglec-E, and Neu1 Regulates MyD88- and TRIF-Dependent Pathways for TLR4-Activation During
    Karmakar J; Mandal C
    Front Immunol; 2021; 12():626110. PubMed ID: 33763070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A TLR4-TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells.
    Dyevoich AM; Disher NS; Haro MA; Haas KM
    Cancer Immunol Immunother; 2020 Oct; 69(10):2113-2124. PubMed ID: 32448982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monophosphoryl lipid a attenuates radiation injury through TLR4 activation.
    Guo J; Chen Y; Lei X; Xu Y; Liu Z; Cai J; Gao F; Yang Y
    Oncotarget; 2017 Oct; 8(49):86031-86042. PubMed ID: 29156775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short- and long-term regulation of intestinal Na+/H+ exchange by Toll-like receptors TLR4 and TLR5.
    Cabral JM; Grácio D; Soares-da-Silva P; Magro F
    Am J Physiol Gastrointest Liver Physiol; 2015 Oct; 309(8):G703-15. PubMed ID: 26294670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TSC1 Suppresses Macrophage Necroptosis for the Control of Infection by Fungal Pathogen
    Li T; Xie Y; Shi L; Sun Y; Wen J; Deng Z; Zhang H; Li H; Yang J; Xiao H
    Immunohorizons; 2021 Feb; 5(2):90-101. PubMed ID: 33597177
    [No Abstract]   [Full Text] [Related]  

  • 37. Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans.
    Blasi E; Mucci A; Neglia R; Pezzini F; Colombari B; Radzioch D; Cossarizza A; Lugli E; Volpini G; Del Giudice G; Peppoloni S
    FEMS Immunol Med Microbiol; 2005 Apr; 44(1):69-79. PubMed ID: 15849871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells.
    Sun X; Hosomi K; Shimoyama A; Yoshii K; Lan H; Wang Y; Yamaura H; Nagatake T; Ishii KJ; Akira S; Kiyono H; Fukase K; Kunisawa J
    Int Immunopharmacol; 2023 Apr; 117():109852. PubMed ID: 36806039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TLR4-mediated pro-inflammatory dendritic cell differentiation in humans requires the combined action of MyD88 and TRIF.
    Kolanowski ST; Dieker MC; Lissenberg-Thunnissen SN; van Schijndel GM; van Ham SM; ten Brinke A
    Innate Immun; 2014 May; 20(4):423-30. PubMed ID: 23941760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
    Kolb JP; Casella CR; SenGupta S; Chilton PM; Mitchell TC
    Sci Signal; 2014 Nov; 7(351):ra108. PubMed ID: 25389373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.